Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL216357 | 0.91 | SOAT1 (0.46) | SOAT1ALDH1A1NAAAHCAR2TDP1 | |
| SCHEMBL5560623 | 0.89 | ALDH1A1 (0.36) | SOAT1ALDH1A1NAAAHCAR2TDP1 | |
| SCHEMBL11770603 | 0.89 | SOAT1 (0.62) | SOAT1ALDH1A1NAAAHCAR2LMNA | |
| SCHEMBL4757133 | 0.88 | FFAR3 (0.33) | SOAT1ALDH1A1NAAAHCAR2FFAR3 | |
| SCHEMBL4776902 | 0.86 | ALDH1A1 (0.35) | SOAT1ALDH1A1NAAAHCAR2TDP1 | |
| SCHEMBL42970 | 0.85 | ALDH1A1 (0.44) | SOAT1ALDH1A1NAAAHCAR2TDP1 | |
| SCHEMBL1728394 | 0.85 | SOAT1 (0.39) | SOAT1ALDH1A1NAAAHCAR2 | |
| SCHEMBL1960272 | 0.83 | NAAA (0.48) | SOAT1ALDH1A1NAAAHCAR2 | |
| SCHEMBL193251 | 0.82 | HCAR2 (0.40) | SOAT1ALDH1A1NAAAHCAR2TDP1 | |
| SCHEMBL27524303 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8920796-B2 | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8865161-B2 | Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORPORATION (JP) | 2014-10-21 | — | — | US | disclosed |
| US-8440228-B2 | Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORPORATION (JP) | 2013-05-14 | — | — | US | disclosed |
| US-20120244195-A1 | ADSORBENT FOR AN ORAL ADMINISTRATION, AND AGENT FOR TREATING OR PREVENTING RENAL OR LIVER DISEASE | KUREHA CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20080081073-A1 | Surface treated and oxidized spherical activated carbon prepared from crosslinked vinyl resin, ion-exchange resin, or pitch; adsorbs large amount of toxins during retention period in an intestine; reduction of urinary protein excretion | KUREHA CORPORATION (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1525886-B1 | Absorbent for oral administration, and agent for treating or preventing renal or liver disease | KUREHA CORP (JP) | 2008-03-12 | — | — | EP | disclosed |
| US-20080044477-A1 | Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease | KUREHA CORPORATION (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080031972-A1 | Process For Manufacturing Spherical Activated Carbon | KUREHA CORPORATION (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1748031-A1 | METHOD FOR PRODUCING SPHERICAL ACTIVATED CARBON | Kureha Corporation (JP) | 2007-01-31 | — | — | EP | disclosed |
| EP-1745792-A1 | ADSORBENT FOR ORAL ADMINISTRATION, PREVENTIVE OR REMEDY FOR KIDNEY DISEASE AND PREVENTIVE OR REMEDY FOR LIVER DISEASE | Kureha Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1745793-A1 | ADSORBENT FOR ORAL ADMINISTRATION, THERAPEUTIC OR PREVENTIVE AGENT FOR KIDNEY DISEASE, AND THERAPEUTIC OR PREVENTIVE AGENT FOR LIVER DISEASE | Kureha Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| US-20050112114-A1 | Surface treated active carbon; controlling particle sizes, porosity | KUREHA CHEMICAL INDUSTRY CO., LTD. | 2005-05-26 | — | — | US | disclosed |
| EP-1525886-A1 | Absorbent for oral administration, and agent for treating or preventing renal or liver disease | Kureha Chemical Industry Co., Ltd. (JP) | 2005-04-27 | — | — | EP | disclosed |